Study to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Monoclonal Antibody (BMS-986446) in Participants With Early Alzheimer's Disease
Clinical trial NCT06268886 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06268886
- Sponsor
- Bristol-Myers Squibb
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-20
- Primary completion
- 2027-03-18
- Enrollment
- 310
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.